Form 4 holding
Chief Scientific Officer
ADARx Pharmaceuticals, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 170,692
- Estimated value
- Report date
- 24 Sep 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount